Healthcare professionals are pivotal in assessing the risk of patients having metabolic associated fatty liver disease (MAFLD) and its link with metabolic disease progression
What indicators to look out for, given fatty liver can occur in the absence of raised transaminases
The importance of using calculators like the Fib4, when to ask a patient to have a fibrous scan, interpretation of results and when to refer to a specialist
Consensus guidelines on MAFLD expected later in 2024, and what learning courses to consider



Host: Dr David Lim | Total Time: 25 mins

Expert: Prof Simone Strasser, Hepatologist

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

<ul> <li>Healthcare professionals are pivotal in assessing the risk of patients having metabolic associated fatty liver disease (MAFLD) and its link with metabolic disease progression</li> <li>What indicators to look out for, given fatty liver can occur in the absence of raised transaminases</li> <li>The importance of using calculators like the Fib4, when to ask a patient to have a fibrous scan, interpretation of results and when to refer to a specialist</li> <li>Consensus guidelines on MAFLD expected later in 2024, and what learning courses to consider</li> </ul>   Host: Dr David Lim | Total Time: 25 mins Expert: Prof Simone Strasser, Hepatologist Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEDT <a href="https://www.healthed.com.au/webcast/">Click here to register for the next one</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

The Clinical Takeaway podcast for healthcare professionals features leading experts on important topics that can positively change the way you practice. Each episode is eligible for continued professional development (CPD).